ACHN
Achillion Pharmaceuticals, Inc.
ACHN
ACHN
Delisted
ACHN was delisted on the 27th of January, 2020.
149 hedge funds and large institutions have $327M invested in Achillion Pharmaceuticals, Inc. in 2017 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 55 increasing their positions, 32 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
149
Holders Change
+24
Holders Change %
+19.2%
% of All Funds
3.38%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.05%
New
36
Increased
55
Reduced
32
Closed
12
Calls
$983K
Puts
$617K
Net Calls
+$366K
Net Calls Change
-$365K
Top Buyers
| 1 |
RI
RTW Investments
New York
|
+$16.4M |
| 2 |
Morgan Stanley
New York
|
+$12.4M |
| 3 |
EC
EcoR1 Capital
San Francisco,
California
|
+$5.3M |
| 4 |
BlackRock
New York
|
+$5M |
| 5 |
BI
BVF Inc
San Francisco,
California
|
+$4.63M |
Top Sellers
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$37.6M |
| 2 |
O
OrbiMed
New York
|
-$14.1M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$8.61M |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
-$8.27M |
| 5 |
AC
Armistice Capital
New York
|
-$4.58M |
